Role of oxidatively modified LDL in atherosclerosis

Fowler, 1979, Characterization of lipid-laden aortic cells from choleterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations, Lab. Invest., 4, 372 Schaffner, 1980, Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages, Am. J. Pathol., 100, 57 Gerrity, 1981, The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions, Am. J. Pathol., 1–3, 181 Gerrity, 1981, The role of the monocyte in atherogenesis. II. Migration of foam cells from atherosclerotic lesions, Am. J. Pathol., 103, 191 Faggiotto, 1984, Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation, Arteriosclerosis, 4, 323, 10.1161/01.ATV.4.4.323 Aqel, 1984, Monocytic origin of foam cells in human atherosclerotic plaques, Atherosclerosis, 53, 265, 10.1016/0021-9150(84)90127-8 Rosenfield, 1987, Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits, Arteriosclerosis, 7, 9, 10.1161/01.ATV.7.1.9 Goldstein, 1979, Binding site on macrophages that mediates the uptake and degradation of actylated low density lipoprotein, producing massive cholesterol deposition, 76, 333 Brown, 1980, The scavenger cell pathway for lipoprotein degration: specificity of the binding site that mediates the uptake of negatively charged LDL by macrophages, J. Supramol. Struct., 13, 67, 10.1002/jss.400130107 Brown, 1983, Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in the macrophage: implications for cholesterol deposition in atherosclerosis, Ann. Rev. Biochem., 52, 223, 10.1146/annurev.bi.52.070183.001255 Fogelman, 1980, Malondialdehyde alteration of low density lipoprotein leads to cholesterol accumulation in human monocyte macrophages, 77, 214 Haberland, 1982, Specificity of receptor mediated recognition of malondialdehyde modified low density lipoproteins, 79, 1712 Henriksen, 1981, Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by the receptor for acetylated low density lipoproteins, 78, 6499 Henriksen, 1983, Enhanced macrophage degration of biologically modified low density lipoprotein, Arteriosclerosis, 3, 149, 10.1161/01.ATV.3.2.149 Heinecke, 1986, Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells, J. Clin. Invest., 77, 757, 10.1172/JCI112371 Morel, 1983, Low density lipoprotein cytotoxicity induced by free radical perodixation of lipid, J. Lipid Res., 24, 1070, 10.1016/S0022-2275(20)37921-9 Hessler, 1983, Lipoprotein oxidation and lipoprotein-induced cytotoxicity, Arteriosclerosis, 3, 215, 10.1161/01.ATV.3.3.215 Morel, 1984, Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation, Arteriosclerosis, 4, 357, 10.1161/01.ATV.4.4.357 Steinbrecher, 1984, Modification of low density lipoprotein in by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, 81, 3883 Steinbrecher, 1988, Role of superoxide in endothelial-cell modification of low-density lipoproteins, Biochim. Biophys. Acta, 959, 20, 10.1016/0005-2760(88)90145-2 Steinbrecher, 1987, Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism, Arteriosclerosis, 7, 1350143, 10.1161/01.ATV.7.2.135 Steinbrecher, 1987, Oxidation of human low density lipoproteins results in dervatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products, J. Biol. Chem., 262, 3603, 10.1016/S0021-9258(18)61395-X Steinberg, 1988, Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis., 18, 1 Steinberg, 1989, Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity, N. Engl. J. Med., 320, 915, 10.1056/NEJM198904063201407 Jurgens, 1987, Modification of human serum low density lipoprotein by oxidation—characterization and pathophysiologic implications, Chem. Phys. Lipids, 45, 315, 10.1016/0009-3084(87)90070-3 Heinecke, 1987, Free radical modification of low-density lipoprotein: mechanisms and biological consequences, Free Radical Biol. Med., 3, 65, 10.1016/0891-5849(87)90040-2 DiCorleto, 1986, Participation of the endothelium in the development of the atherosclerotic plaque, Prog. Lipid Res., 25, 365, 10.1016/0163-7827(86)90074-3 Hennig, 1988, Lipid peroxidation and endothelial cell injury: implications in atherosclerosis, Free Radical Biol. Med., 4, 99, 10.1016/0891-5849(88)90070-6 Cathcart, 1985, Monocytes and neutrophils oxidize low density lipoproteins making it cytotoxic, J. Leukocyte Biol., 38, 341, 10.1002/jlb.38.2.341 Pathasarathy, 1986, Macrophage oxidation of low density lipoprotein generates a form recognized by the scavenger receptor, Arteriosclerosis, 6, 505, 10.1161/01.ATV.6.5.505 Hiramatsu, 1987, Superoxide initiates oxidation of low density lipoprotein by human monocytes, Arteriosclerosis, 7, 55, 10.1161/01.ATV.7.1.55 Cathcart, 1988, Oxidation modification of low density lipoprotein by activated human monocytes and the cell lines U937 and HL60, In Vitro Cell. Dev. Biol., 24, 1001, 10.1007/BF02620873 Cathcart, 1989, Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin, J. Immunol., 142, 1963 Bedwell, 1989, The action of defined oxygen-centered free radicals on human low-density lipoprotein, Biochem. J., 262, 707, 10.1042/bj2620707 Parthasarathy, 1989, A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein, 86, 1046 Heinecke, 1987, The role of sulfur-containing amino acids in superoxide production by arterial smooth muscle cells, J. Biol. Chem., 262, 10098, 10.1016/S0021-9258(18)61082-8 Parthasarthy, 1987, Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor, Biochim. Biophys. Acta, 917, 337, 10.1016/0005-2760(87)90139-1 Heinecke, 1984, Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture, J. Clin. Invest., 74, 1890, 10.1172/JCI111609 Esterbauer, 1987, Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes, J. Lipid Res., 28, 495, 10.1016/S0022-2275(20)38678-8 Quintao, 1989, Role of β-carotene in the oxidative modification of low density lipoproteins, Arteriosclerosis, 9, 758a Mahley, 1979, Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysines residues of the apoproteins, J. Clin. Invest., 64, 743, 10.1172/JCI109518 Haberland, 1984, Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages, J. Biol. Chem., 259, 11305, 10.1016/S0021-9258(18)90863-X Steinbrecher, 1989, Recognition of oxidized low density lipoprotein by teh scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation, J. Biol. Chem., 264, 15216, 10.1016/S0021-9258(19)84812-3 Fukuzawa, 1985, Fluorescent pigments by covalent binding of lipid peroxidation by-products to protein and amino acids, Lipids, 20, 854, 10.1007/BF02534768 Kikugawa, 1984, Studies of peroxidized lipids: fluorescent products derived from the reaction of unsaturated fatty acids and methylamine, Chem. Pharm. Bull., 32, 638, 10.1248/cpb.32.638 Kikugawa, 1985, Polylysines modified with malondialdephyde, hydroperoxylinoleic acid, and monofunctional aldehydes, Chem. Pharm. Bull., 33, 5437, 10.1248/cpb.33.5437 Quehenberger, 1987, Investigation of lipid peroxidation in human low density lipoprotein, Free Radical Res. Commun., 3, 233, 10.3109/10715768709069788 Via, 1985, Murine macrophage tumors are a source of a 260,000-dalton acetyl-low density lipoprotein receptor, J. Biol. Chem., 260, 7379, 10.1016/S0021-9258(17)39619-9 Dresel, 1987, Binding of acetylated low density lipoprotein and maleylated bovine serum albumin to the rat liver: one or two receptors?, EMBO J., 6, 319, 10.1002/j.1460-2075.1987.tb04757.x Kodama, 1988, Purification and characterization of a bovine acetyl low density lipoprotein receptor, 85, 9238 Kodama, 1990, Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils, Nature, 343, 532, 10.1038/343531a0 Rohrer, 1990, Coiled-coil fibrous domains mediate by the macrophage scavenger receptor type II, Nature, 343, 570, 10.1038/343570a0 Haberland, 1986, Two distinct receptors account for recognition of maleylalbumin in human monocytes during differentiation in vitro, J. Clin. Invest., 77, 681, 10.1172/JCI112362 Horiuchi, 1986, Scavenger receptor for aldehyde-modified proteins, J. Biol. Chem., 261, 4962, 10.1016/S0021-9258(19)89199-8 Takata, 1989, Scavenger receptor-mediated recognition of maleylated albumin and its relation to subsequent endocytic degradation, Biochim. Biophys. Acta, 984, 273, 10.1016/0005-2736(89)90293-9 Sparrow, 1989, A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein, J. Biol. Chem., 264, 2599, 10.1016/S0021-9258(19)81655-1 Arai, 1989, Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins, Biochem. Biophys. Res. Commun., 159, 1375, 10.1016/0006-291X(89)92262-6 Gianturco, 1989, Human macropahge receptor pathway and membrane binding proteins for human abnormal triglyceride-rich lipoproteins bindi oxidized LDL, Arteriosclerosis, 9, 699a Yokode, 1988, Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract, 85, 2344 Hoberman, 1988, Reaction of tobacco smoke aldehydes with human hemoglobin, J. Biochem. Toxicol., 3, 105, 10.1002/jbt.2570030205 Harats, 1989, Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages, Atherosclerosis, 79, 245, 10.1016/0021-9150(89)90130-5 Nagelkerke, 1984, In vivo catabolism of biologically modified LDL, Arteriosclerosis, 4, 256, 10.1161/01.ATV.4.3.256 Pitas, 1985, Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells, J. Cell. Biol., 100, 103, 10.1083/jcb.100.1.103 Gorog, 1987, Increased uptake of monocyte-treaated low density lipoproteins by aortic endothelium in vivo, Atherosclerosis, 65, 99, 10.1016/0021-9150(87)90011-6 Steinbrecher, 1989, Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase, J. Lipid Res., 30, 305, 10.1016/S0022-2275(20)38359-0 Wardlow, 1986, Substrate specificity and partial characterization of the PAF acylhydrolase in human serum that rapidly inactiavates platelet activating factor, J. Immunol., 136, 3441 Stafforini, 1987, Human platelet activating factor acetylhydrolase: association with lipoprotein particles and role in the degradation of platelet-activating factor, J. Biol. Chem., 262, 4223, 10.1016/S0021-9258(18)61336-5 Stremler, 1989, An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma, J. Biol. Chem., 264, 5331, 10.1016/S0021-9258(18)83548-7 Quinn, 1988, Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis, 85, 2805 Ungemach, 1987, Pathobiochemical mechanisms of hepatocellular damage following lipid peroxisation, Chem. Phys. Lipids, 45, 171, 10.1016/0009-3084(87)90065-X Serhan, 1981, Phosphatidate and oxidized fatty acids are calcium ionophores, J. Biol. Chem., 256, 2736, 10.1016/S0021-9258(19)69677-8 Henriksen, 1979, Injury to human endothelial cells in culture induced by low density lipoproteins, Scand. J. Clin. Lab. Invest., 39, 361, 10.3109/00365517909106120 Hessler, 1979, LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture, Atherosclerosis, 32, 213, 10.1016/0021-9150(79)90166-7 Jain, 1984, The accumulation of malondialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes, J. Biol. Chem., 269, 3391, 10.1016/S0021-9258(17)43104-8 Basu, 1983, Unequivocal demonstration that malondialdehyde is a mutagen, Carcinogenesis, 4, 331, 10.1093/carcin/4.3.331 O'Brien, 1987, Oxidation of lipids in biological membranes and intracellular consequences, 233 Kosugi, 1987, Toxicity of oxidized low density lipoprotein to cultured fibroblasts is selective for the S phase of the cell cycle, J. Cell. Physiol., 102, 119 Zhang, 1990, Effects of oxidatively modified LDL on cholesterol esterification in macrophages, J. Lipid Res., 10.1016/S0022-2275(20)42607-0 Jialal, 1989, Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein, J. Lipid Res., 30, 1561, 10.1016/S0022-2275(20)38240-7 Morin, 1989, The role of cholesterol oxidation products in the pathogenesis of atherosclerosis, Ann. Clin. Lab. Sci., 19, 225 Triau, 1988, Oxidized low density lipoprotein stimulates prostacyclin production by adult vascular endothelial cells, Arteriosclerosis, 8, 810, 10.1161/01.ATV.8.6.810 Yokode, 1988, Stimulated arachdonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein, J. Clin. Invest., 81, 720, 10.1172/JCI113377 Szczeklik, 1980, Low density lipoproteins are carriers for lipid peroxides and inhibit prostacyclin biosynthesis in arteries, Artery, 7, 488 Zhang, 1990, The effects of oxidized low density lipoproteins on arachidonic acid metabolism in smooth muscle cells, J. Lipid Res., 31, 551, 10.1016/S0022-2275(20)42824-X Taylor, 1983, The participation of hydroperoxides and oxygen radicals in the control of prosta glandin synthesis, J. Biol. Chem., 258, 6855, 10.1016/S0021-9258(18)32301-9 Lands, 1980, Lipid peroxide actions in the regulation of prostaglandin biosynthesis, vol. 6, 39 Ardle, 1989, Platelet activation by oxidatively modified low density lipoprotein, Atherosclerosis, 76, 117, 10.1016/0021-9150(89)90094-4 Fox, 1987, Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation, J. Biol. Chem., 262, 6046, 10.1016/S0021-9258(18)45535-4 Hamilton, 1990, Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor—alpha mRNA in stimulated murine peritoneal macrophages, J. Immunol., 144, 2343 Rajavashisth, 1990, Induction of endothelial cell expression of granulocyte and monocyte-macrophage chemotactic factors by modified low density lipoproteins, Nature, 344, 254, 10.1038/344254a0 Cushing, 1990, Minimally modified low density lipoprotein induces monocyte chemotactic protein (MCP-1) in human endothelial and smooth muscle cells Berliner, 1990, Minimally modified LDL stimulates monocyte endothelial interactions, J. Clin. Invest., 85, 1260, 10.1172/JCI114562 Frostegard, 1990, Oxidized low density lipoprotein induces the differentiation and adhesion of human monocytes and the monocytic cell line U937, 87, 904 Schuh, 1978, Oxygen- mediated heterogeneity of apo-low-density lipoprotein, 75, 3173 Yagi, 1987, Lipid peroxides and human diseases, Chem. Phys. Lipids, 45, 337, 10.1016/0009-3084(87)90071-5 Avogaro, 1988, Presence of a modified low density lipoprotein in humans, Arteriosclerosis, 8, 79, 10.1161/01.ATV.8.1.79 Salmon, 1987, Immunological detection of low-density lipoproteins modified by malondialdehyde in vitro or in vivo, Biochim. Biophys. Acta, 920, 215, 10.1016/0005-2760(87)90097-X Morel, 1989, Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity, J. Lipid Res., 30, 1827, 10.1016/S0022-2275(20)38196-7 Frei, 1988, Evalaution of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma, Anal. Biochem., 175, 120, 10.1016/0003-2697(88)90369-7 Hoff, 1982, Isolation, purification and characterization of a lipoprotein containing apo B from the human aorta, 273 Clevidence, 1984, Cholesterol esterification in marcophages. Stimulation by lipoproteins containing apo B isolated from human aortas, Arteriosclerosis, 4, 196, 10.1161/01.ATV.4.3.196 Yla-Herttula, 1988, Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima, J. Lipid Res., 29, 563, 10.1016/S0022-2275(20)38503-5 Daugherty, 1988, Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits, Arteriosclerosis, 8, 768, 10.1161/01.ATV.8.6.768 Haberland, 1988, Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits, Science, 241, 215, 10.1126/science.2455346 Palinski, 1989, Low density lipoprotein undergoes oxidative modification in vivo, 86, 1372 Boyd, 1989, Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit, Am. J. Pathol., 135, 815 Mowri, 1988, Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions, Biochim. Biophys. Acta, 963, 208, 10.1016/0005-2760(88)90282-2 Yla-Herttuala, 1989, Evidence for the presence of oxidatively modified LDL in atherosclerotic lesions of rabbit and man, J. Clin. Invest., 84, 1086, 10.1172/JCI114271 Steinberger, 1989, Correlation of oxidative change in LDL from human aorta with effects on cholesterol esterification in macrophages, Arteriosclerosis, 9, 764a Parthasarathy, 1986, Probucol inhibits oxidative modification of low density lipoprotin, J. Clin. Invest., 77, 641, 10.1172/JCI112349 Carew, 1987, Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atharosclerosis in the Watanabe heritable hyperlipidemic rabbit, 84, 7725 Kita, 1987, Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia, 84, 5928 Wiklund, 1989, Cellular uptake and degradation of LDL and modified LDL in atherosclerosis rabbit aorta. Studies in an in vitro perfusion system, Arteriosclerosis, 9, 704a Stein, 1989, Lack of effect of probucol on atheroma formation in cholesterol-fed rabbit kept at comparable plasma cholesterol levels, Atherosclerosis, 75, 145, 10.1016/0021-9150(89)90171-8 Morton, 1986, A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism, J. Lipid Res., 27, 1124, 10.1016/S0022-2275(20)38749-6 Hoff, 1988, Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages, Atherosclerosis, 70, 29, 10.1016/0021-9150(88)90097-4 Frie, 1988, Antioxidant defenses and lipid peroxidation in human blood plasma, 85, 9748